Raul Insa ^UDM

Raúl Insa is the founder of SOM Biotech, a biopharmaceutical company specializing in accelerated discovery and development of therapies for orphan indications. SOM Biotech employs a proprietary artificial intelligence-based drug discovery technology and collaborates with major research centers and pharmaceutical companies. Their SOM AI PRO Technology, a proprietary AI-based validated drug discovery technology, has successfully completed the Clinical Phase 2a of two drugs with positive results for treating neurodegenerative diseases. SOM Biotech aims at developing collaborations to leverage the potential of SOMAI-PRO in discovering new treatments for acute diseases and accelerating the drug discovery process.